CHARACTERIZATION OF FUNDIC MUCOSAL CELLS IN VITRO
CHARACTERIZATION OF FUNDIC MUCOSAL CELLS IN VITRO
批准号:
3152067
负责人:
Andrew H. Soll
金额:
$15.98万
依托单位国家:
美国
项目类别:
财政年份:
1982
资助国家:
美国
项目状态:
已结题
起止时间:
1982-03-01 至 1990-08-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The overall objectives of this proposal are to study cellular mechanisms
underlying secretory function and mucosal resistance to acid-peptic
injury. A major focus is to use cell separation techniques to identify the
cells producing prostaglandins (PG) in the canine fundic mucosa. PGs will
be measured by radioimmunoassay, confirmed by thin layer chromatography.
We will verify our recent finding that isolated canine fundic macrophages
(CFM) produce large amounts of PGs. Monitoring Factor VIII-related
antigen, endothelial cells will be enriched and PG production determined.
The regulation of PG formation by fundic macrophages, endothelial cells and
mucosal cells will be compared. We will confirm our preliminary finding
that CFM produce superoxides in response to phagocytic stimuli, and test
the hypothesis that CFM may mediate gastric injury via release of oxygen
radicals, lysosomal enzymes, thromboxane and leukotrienes.
The mechanisms of secretory cell activation will be studied focusing on the
role of cyclic AMP and Ca++. Cytoplasmic [Ca++] will be monitored using
Quin2 fluorescence techniques and isotopic flux studies. The role of
phosphoinositide turnover in cell activation will be studied in
relationship to modulation of cytosolic Ca++ and activation of protein
kinase C. The approach will be developed studying chief cells and then
applied to parietal and somatostatin cells and, as appropriate, to fundic
mast cells and fundic macrophages. Contrasts between activation or
inhibition of cell function by various chemotransmitters will provide the
critical tool for establishing the specificity and relevance of these cell
activation mechanisms.
Culture techniques for chief cell monolayers will be refined, focusing on
developing conditions (substrates, defined serum-free medium, and
conditioned medium) for maintaining differentiation. These monolayers
resist a very large H+ gradient and the hypothesis will be tested that
specialization of the apical surface underlies barrier function. The
resistance of chief cell monolayers to H+ backdiffusion will be studied by
electrophysiological and morphological techniques, and differences with
nongastric epithelial cells determined. A role for chief cell basolateral
membrane acid disposal in cellular resistance to acid-peptic injury will be
explored.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Oxygen metabolites modulate prostaglandin E2 production by isolated gastric mucosal cells.
氧代谢物调节分离的胃粘膜细胞产生前列腺素 E2。
DOI:
10.1152/ajpgi.1989.256.5.g925
发表时间:
1989
期刊:
The American journal of physiology
影响因子:
--
作者:
[Olson,CE, Chen,MC, Amirian,DA, Soll,AH]
通讯作者:
Soll,AH
The apical surface of canine chief cell monolayers resists H+ back-diffusion.
犬主细胞单层的顶端表面抵抗 H 反向扩散。
DOI:
10.1038/313052a0
发表时间:
1985
期刊:
Nature
影响因子:
64.8
作者:
[Sanders,MJ, Ayalon,A, Roll,M, Soll,AH]
通讯作者:
Soll,AH
DOI:
10.1172/jci115189
发表时间:
1991-05
期刊:
The Journal of clinical investigation
影响因子:
--
作者:
[Monica C. Chen;Alexander T. Lee;A. H. Soll]
通讯作者:
Monica C. Chen;Alexander T. Lee;A. H. Soll
Glutathione modulates toxic oxygen metabolite injury of canine chief cell monolayers in primary culture.
谷胱甘肽调节原代培养中犬主细胞单层的有毒氧代谢损伤。
DOI:
10.1152/ajpgi.1988.254.1.g49
发表时间:
1988
期刊:
The American journal of physiology
影响因子:
--
作者:
[Olson,CE]
通讯作者:
Olson,CE
Online patient self-assessment system for care and research of joint and skin dis
-
批准号:8253540
-
项目类别:
-
资助金额:$38.6万
-
财政年份:2012
-
负责人:Andrew H. Soll
-
依托单位:
Web-based Biopsychosocial Assessment and Intervention for Alcohol Misuse
-
批准号:8061740
-
项目类别:
-
资助金额:$33.1万
-
财政年份:2011
-
负责人:Andrew H. Soll
-
依托单位:
Online patient self-assessment for chronic pancreatic and other pain
-
批准号:8203244
-
项目类别:
-
资助金额:$39.78万
-
财政年份:2011
-
负责人:Andrew H. Soll
-
依托单位:
Integrated Online Assessment and Intervention Targeting Health Disparities
-
批准号:8077099
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2011
-
负责人:Andrew H. Soll
-
依托单位:
Integrated Online Assessment and Intervention Targeting Health Disparities
-
批准号:8290215
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2011
-
负责人:Andrew H. Soll
-
依托单位:
Development of a Health Policy Tool for Prioritizing Health Disparities Targets
-
批准号:7803942
-
项目类别:
-
资助金额:$18.52万
-
财政年份:2009
-
负责人:Andrew H. Soll
-
依托单位:
Comprehensive Management Strategy for GI Disorders
-
批准号:6887574
-
项目类别:
-
资助金额:$159.58万
-
财政年份:2004
-
负责人:Andrew H. Soll
-
依托单位:
Comprehensive Management Strategy for GI Disorders
-
批准号:7680782
-
项目类别:
-
资助金额:$2.56万
-
财政年份:2004
-
负责人:Andrew H. Soll
-
依托单位:
Comprehensive Management Strategy for GI Disorders
-
批准号:6954244
-
项目类别:
-
资助金额:$21.34万
-
财政年份:2004
-
负责人:Andrew H. Soll
-
依托单位:
COMPUTERIZED PATIENT SELF-ASSESSMENT FOR RHEUMATOLOGY
-
批准号:6694494
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2003
-
负责人:Andrew H. Soll
-
依托单位:
COMPREHENSIVE MANAGEMENT STRATEGY FOR GI DISORDERS
-
批准号:6211099
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2000
-
负责人:Andrew H. Soll
-
依托单位:
DEVELOPMENT OF A COMPREHENSIVE PATIENT MANAGEMENT SYSTEM
-
批准号:2746570
-
项目类别:
-
资助金额:$10.0万
-
财政年份:1998
-
负责人:Andrew H. Soll
-
依托单位:
DEVELOPMENT OF A COMPREHENSIVE PATIENT MANAGEMENT SYSTEM
-
批准号:6142549
-
项目类别:
-
资助金额:$40.29万
-
财政年份:1998
-
负责人:Andrew H. Soll
-
依托单位:
DEVELOPMENT OF A COMPREHENSIVE PATIENT MANAGEMENT SYSTEM
-
批准号:6363010
-
项目类别:
-
资助金额:$34.71万
-
财政年份:1998
-
负责人:Andrew H. Soll
-
依托单位:
DEVELOPMENT OF A COMPREHENSIVE PATIENT MANAGEMENT SYSTEM
-
批准号:6587897
-
项目类别:
-
资助金额:$25.0万
-
财政年份:1998
-
负责人:Andrew H. Soll
-
依托单位:
FUNDIC MUCOSAL CELLS IN VITRO
-
批准号:2138384
-
项目类别:
-
资助金额:$18.99万
-
财政年份:1982
-
负责人:Andrew H. Soll
-
依托单位:
CHARACTERIZATION OF FUNDIC MUCOSAL CELLS IN VITRO
-
批准号:3229471
-
项目类别:
-
资助金额:$18.78万
-
财政年份:1982
-
负责人:Andrew H. Soll
-
依托单位:
CHARACTERIZATION OF FUNDIC MUCOSAL CELLS IN VITRO
-
批准号:3229465
-
项目类别:
-
资助金额:$19.81万
-
财政年份:1982
-
负责人:Andrew H. Soll
-
依托单位:
CHARACTERIZATION OF FUNDIC MUCOSAL CELLS IN VITRO
-
批准号:3229470
-
项目类别:
-
资助金额:$16.7万
-
财政年份:1982
-
负责人:Andrew H. Soll
-
依托单位:
CHARACTERIZATION OF FUNDIC MUCOSAL CELLS IN VITRO
-
批准号:3229467
-
项目类别:
-
资助金额:$14.5万
-
财政年份:1982
-
负责人:Andrew H. Soll
-
依托单位: